|
1
|
Naik PN, Chimatadar SA and Nandibewoor ST:
Interaction between a potent corticosteroid drug - dexamethasone
with bovine serum albumin and human serum albumin: a fluorescence
quenching and fourier transformation infrared spectroscopy study. J
Photochem Photobiol B. 100:147–159. 2010. View Article : Google Scholar
|
|
2
|
Ishida Y and Heersche JN:
Glucocorticoid-induced osteoporosis: both in vivo and in vitro
concentrations of glucocorticoids higher than physiological levels
attenuate osteoblast differentiation. J Bone Miner Res.
13:1822–1826. 1998. View Article : Google Scholar
|
|
3
|
Atmani H, Chappard D and Basle MF:
Proliferation and differentiation of osteoblasts and adipocytes in
rat bone marrow stromal cell cultures: effects of dexamethasone and
calcitriol. J Cell Biochem. 89:364–372. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coelho MJ and Fernandes MH: Human bone
cell cultures in biocompatibility testing. Part II: effect of
ascorbic acid, beta-glycerophosphate and dexamethasone on
osteoblastic differentiation. Biomaterials. 21:1095–1102. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hakki SS, Nohutcu RM, Hakki EE, Berry JE,
Akkaya MS and Somerman MJ: Dexamethasone and basic-fibroblast
growth factor regulate markers of mineralization in cementoblasts
in vitro. J Periodontol. 76:1550–1558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mansukhani A, Bellosta P, Sahni M and
Basilico C: Signaling by fibroblast growth factors (FGF) and
fibroblast growth factor receptor 2 (FGFR2)-activating mutations
blocks mineralization and induces apoptosis in osteoblasts. J Cell
Biol. 149:1297–1308. 2000. View Article : Google Scholar
|
|
7
|
Xiao G, Jiang D, Gopalakrishnan R and
Franceschi RT: Fibroblast growth factor 2 induction of the
osteocalcin gene requires MAPK activity and phosphorylation of the
osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem.
277:36181–36187. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sobue T, Naganawa T, Xiao L, et al:
Over-expression of fibroblast growth factor-2 causes defective bone
mineralization and osteopenia in transgenic mice. J Cell Biochem.
95:83–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kotev-Emeth S, Pitaru S, Pri-Chen S and
Savion N: Establishment of a rat long-term culture expressing the
osteogenic phenotype: dependence on dexamethasone and FGF-2.
Connect Tissue Res. 43:606–612. 2002. View Article : Google Scholar
|
|
10
|
Lee SY, Lim J, Khang G, et al: Enhanced ex
vivo expansion of human adipose tissue-derived mesenchymal stromal
cells by fibroblast growth factor-2 and dexamethasone. Tissue Eng
Part A. 15:2491–2499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park JB: Low dose of doxycyline promotes
early differentiation of preosteoblasts by partially regulating the
expression of estrogen receptors. J Surg Res. 178:737–742. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JB: The effects of dexamethasone,
ascorbic acid, and β-glycerophosphate on osteoblastic
differentiation by regulating estrogen receptor and osteopontin
expression. J Surg Res. 173:99–104. 2012.
|
|
13
|
Park JB: Combination of simvastatin and
bone morphogenetic protein-2 enhances differentiation of
osteoblastic cells by regulating the expressions of
phospho-Smad1/5/8. Exp Ther Med. 4:303–306. 2012.PubMed/NCBI
|
|
14
|
Park JB: Effects of fibroblast growth
factor 2 on osteoblastic proliferation and differentiation by
regulating bone morphogenetic protein receptor expression. J
Craniofac Surg. 22:1880–1882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park JB: Effects of doxycycline,
minocycline, and tetracycline on cell proliferation,
differentiation, and protein expression in osteoprecursor cells. J
Craniofac Surg. 22:1839–1842. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beloti MM and Rosa AL: Osteoblast
differentiation of human bone marrow cells under continuous and
discontinuous treatment with dexamethasone. Braz Dent J.
16:156–161. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fakhry A, Ratisoontorn C, Vedhachalam C,
et al: Effects of FGF-2/−9 in calvarial bone cell cultures:
differentiation stage-dependent mitogenic effect, inverse
regulation of BMP-2 and noggin, and enhancement of osteogenic
potential. Bone. 36:254–266. 2005.
|
|
18
|
Nakamura Y, Wakitani S, Nakayama J,
Wakabayashi S, Horiuchi H and Takaoka K: Temporal and spatial
expression profiles of BMP receptors and noggin during
BMP-2-induced ectopic bone formation. J Bone Miner Res.
18:1854–1862. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim CH, Cheng SL and Kim GS: Effects of
dexamethasone on proliferation, activity, and cytokine secretion of
normal human bone marrow stromal cells: possible mechanisms of
glucocorticoid-induced bone loss. J Endocrinol. 162:371–379. 1999.
View Article : Google Scholar
|
